Literature DB >> 10921687

Trends in coronary artery bypass surgery results: a recent, 9-year study.

D Abramov1, M G Tamariz, S E Fremes, V Guru, M A Borger, G T Christakis, G Bhatnagar, J Y Sever, B S Goldman.   

Abstract

BACKGROUND: The demographics of patients undergoing coronary artery bypass grafting (CABG) have changed over time and may contribute to differing operative mortality and the combination of mortality and morbidity (M + M). In this study, the trends in results are analyzed and causes are suggested.
METHODS: Prospectively collected data concerning 4,839 CABG operations was divided into three time cohorts (1990 to 1992, 1993 to 1995, 1996 to 1998) and analyzed by univariate and multivariate techniques.
RESULTS: Mean age and female gender frequency increased in the later time cohorts (60.7 +/- 9.0 to 63.4 +/- 9.9 years and 16.5% to 21.4%, respectively). The following comorbidities were more prevalent in the later time cohorts: diabetes (26.7% versus 18.6%), renal failure (8.5% versus 2.2%), peripheral vascular disease (20.7% versus 11.0%), previous cerebrovascular accident (6.7% versus 5.0%), urgent procedures (41.5% versus 26.9%), unstable angina (47.8% versus 31.7%), urgent CABG following myocardial infarction (17.1% versus 7.3%), previous percutaneous transluminal coronary angioplasty (8.0% versus 4.5%), ejection fraction less than 35% (20.5% versus 10.4%), (all p < 0.05). Procedurally, increased utilization of the left internal mammary artery, multiple arterial conduits, and warm blood cardioplegia occurred in the later cohorts (91.2%, 22.2%, and 80.4% versus 78.7%, 3.4%, and 38.0%, respectively). The mortality rate was 2.0% and the M + M rate was 15.6% in all 4,839 patients. The mortality and M + M for the three cohorts were 1.6%, 2.0%, and 2.3% and 18.4%, 17.2% and 12.5%, respectively. The risk-adjusted mortality and M + M decreased from 2.4% and 15.9%, respectively, in 1990 to 1992 to 1.8% and 8.4% in 1996 to 1998 (p < 0.001). The difference in adjusted event rates was minimized when the surgical factors were entered into the model.
CONCLUSIONS: Over time, there has been a trend toward operating on older patients with more comorbidities. Though hospital mortality has been stable, risk-adjusted M + M has been in a constant decline. This decline was associated with an increased use of left internal mammary artery grafts, multiple arterial conduits, and warm blood cardioplegia during the later years of the study.

Entities:  

Mesh:

Year:  2000        PMID: 10921687     DOI: 10.1016/s0003-4975(00)01249-2

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  19 in total

1.  The new cardiac surgery patient: defying previous expectations.

Authors:  Sandeep K Aggarwal; Stephanie A Fox; Larry Stitt; Bob Kiaii; F Neil McKenzie; Alan H Menkis; Mackenzie A Quantz; Richard J Novick
Journal:  Can J Surg       Date:  2006-04       Impact factor: 2.089

2.  Higher age predicts adverse outcome and readmission after coronary artery bypass grafting.

Authors:  Otso Järvinen; Heini Huhtala; Jari Laurikka; Matti R Tarkka
Journal:  World J Surg       Date:  2003-11-05       Impact factor: 3.352

3.  Changing outcomes of coronary revascularization in British Columbia, 1995-2001.

Authors:  Gordon E Pate; Min Gao; Lillian Ding; Ronald G Carere; Frank O Tyers; Robert I Hayden
Journal:  Can J Cardiol       Date:  2006-12       Impact factor: 5.223

4.  Diabetics have Inferior Long-Term Survival and Quality of Life after CABG.

Authors:  Otso Järvinen; Matti Hokkanen; Heini Huhtala
Journal:  Int J Angiol       Date:  2019-01-02

5.  Management of postoperative atrial fibrillation and subsequent outcomes in contemporary patients undergoing cardiac surgery: insights from the Society of Thoracic Surgeons CAPS-Care Atrial Fibrillation Registry.

Authors:  Benjamin A Steinberg; Yue Zhao; Xia He; Adrian F Hernandez; David A Fullerton; Kevin L Thomas; Roger Mills; Winslow Klaskala; Eric D Peterson; Jonathan P Piccini
Journal:  Clin Cardiol       Date:  2013-12-18       Impact factor: 2.882

6.  [Experiences collected in more than 2,300 diabetics undergoing coronary artery bypass grafting: patients with a specific risk profile].

Authors:  A H Lauruschkat; A Albert; B Arnrich; S Bauer; F Dalladaku; I C Ennker; U Rosendahl; J Ennker
Journal:  Clin Res Cardiol       Date:  2006-01       Impact factor: 5.460

7.  Hospital coronary artery bypass graft surgery volume and patient mortality, 1998-2000.

Authors:  Saif S Rathore; Andrew J Epstein; Kevin G M Volpp; Harlan M Krumholz
Journal:  Ann Surg       Date:  2004-01       Impact factor: 12.969

8.  Mid-term outcomes of patients with PCI prior to CABG in comparison to patients with primary CABG.

Authors:  Sandra Eifert; Helmut Mair; Anne-Laure Boulesteix; Eckehard Kilian; Martin Adamczak; Bruno Reichart; Peter Lamm
Journal:  Vasc Health Risk Manag       Date:  2010-08-09

Review 9.  Protective ischaemia in patients: preconditioning and postconditioning.

Authors:  Asger Granfeldt; David J Lefer; Jakob Vinten-Johansen
Journal:  Cardiovasc Res       Date:  2009-04-27       Impact factor: 10.787

10.  The effect of N-acetyl cysteine injection on renal function after coronary artery bypass graft surgery: a randomized double blind clinical trial.

Authors:  Fatemeh Javaherforooshzadeh; Zahra Shaker; Mahboobeh Rashidi; Reza Akhondzadeh; Fatemeh Hayati
Journal:  J Cardiothorac Surg       Date:  2021-06-05       Impact factor: 1.637

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.